⌘K

Login Start Free

Home/Filings/4/0001213900-17-001711

4//SEC Filing

DelMar Pharmaceuticals, Inc. 4

Accession 0001213900-17-001711

$HURACIK 0001498382operating

View on SEC.gov Company Profile

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 4:24 PM ET

Size

5.3 KB

Accession

0001213900-17-001711

Insider Transaction Report

Form 4

Period: 2017-02-17

DelMar Pharmaceuticals, Inc.DMPI

CEO and President10% Owner

Transactions

Award
Options (Right to Buy)
2017-02-17+93,600→ 93,600 total
Exercise: $4.95From: 2020-02-17Exp: 2027-02-17→ Common Stock (93,600 underlying)

Footnotes (1)

[F1]The options vest in equal monthly installments over three years.

Documents

1 file

4
f4021717bacha_delmarpharma.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

DelMar Pharmaceuticals, Inc.

CIK 0001498382

Entity typeoperating

IncorporatedNV

Related Parties

1

filerCIK 0001498382

Filing Metadata

Form type: 4
Filed: Feb 21, 7:00 PM ET
Accepted: Feb 22, 4:24 PM ET
Size: 5.3 KB

View on SEC.gov